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ABSTRACT (120 words) 
Metformin has anticancer effects by inhibiting glucose metabolism. Hyperthermia sensitizes 
cancer cells. It is known that both metformin,hypo- and hyperthermia deregulate mitochondrial 
metabolism in cancer. However, the mechanism of the additive effect is not known. The 
combined effect of metformin and hypo- or hyperthermia on osteosarcoma cell line (MG-63 cell) 
viability, DNA damage, glucose metabolism, regulation of apoptotic genes and proteins were 
investigated. Osteosarcoma (MG-63) cells were treated with metformin IC50 30M for 48h 
followed by exposure to 45°C, 39°C, 35°C 27°C for 30 min, 1h and 2h , 37°C was served as 
control. The combinations of metformin with hypo- and hyperthermia significantly downregulated 
the expression of AKT1 and GSK3(3 genes, which led to a reduce cells viability and an increase 
in DNA damage. Metformin induced apoptosis and necrosis. The combined effect caused a 
downregulation of anti-apoptotic Bcl-2. The intrinsic pathway was not activated. Therefore, this 
study suggests that the combination of metformin with hyperthermia particularly 45°C, enhances 
apoptosis via Bax/Bid-dependent pathway. 
1. INTRODUCTION 
Osteosarcoma is a malignant bone cancer associated with development of chemotherapy 
resistance. Hypo- and hyperthermia have been used as an adjuvant to radiation therapy as both 
seem to have complimentary effects. Therefore this study aims to combine temperature stress 
which causes cell cycle arrest and DNA damage with drugs that interfere with the energy 
metabolism and/or induce apoptosis. Metformin is known as antiglycemic drug with anticancer 
properties. Metformin has multiple potential applications. Metformin was associated with 
decreased cancer incidence and mortality in diabetic patients and the insulin-lowering effects of 
metformin may be integral to its anticancer properties. In cancer, metformin displays significant 
growth inhibitory effects in several cancer cells and mouse tumor models. Meanwhile, it has 
been suggested that metformin uncouples the TCA cycle from oxidative phosphorylation and 
therefore reduce energy production. In combination with hypo- and hyperthermia, it may 
increase the mitochondrial apoptotic pathway and prevent DNA damage repair program. 
Osteosarcoma is a rare but very aggressive malignant bone cancer. Despite surgery and 
chemotherapy, osteosarcoma has a high recurrence rate and is associated with the 
development of chemotherapy resistance. Therefore the search for alternative treatment 
modalities is still on. Hypo- and hyperthermia have been used as adjuvant mainly to radiation 
and chemotherapy and it has shown to be beneficial and increasing survival rates in several 
types of cancers. However the treatment of osteosarcoma cells with hypo- or hyperthermia is 
not sufficient and an additional treatment is necessary. Metformin interfere with the cells energy 
production and therefore reduce the availability of ATP for other prosurvival pathways. 
Therefore it stands to rationale that metformin would be a good compliment treatment with 
hypo- and hyperthermia for osteosarcoma. 
1. RESEARCH METHODOLOGY 
Osteosarcoma cells (MG-63) were first cultured in Dulbecco's modified Eagle's medium 
(DMEM) containing 10% FBS. Approximately 2,500 MG-63 cells/well were seeded into 96-well 
plates and tested for metformin IC50 dose. Once the concentration of the dose was established 
(IC5o=30M for 48h), MG-63 viability was measured using MTS assay. Cells were preincubated 
with metformin for 48h and exposed to moderate (35°C) and severe (27°C) hypo- also to 
moderate (39°C) and severe (45°C) hyperthermia for 30mins, 1h and 2h. After each time points, 
damage to DNA was accessed by comet assay stained with SYBR® Green and type of cell 
death was determined via Annexin V-FITC and PI staining. Gene and protein expression of 
AKT1 & GSK3P (glucose metabolism), DR5, Bax, Bid, Bcl-2, AIF, cytochrome c, Apafl, 
Caspase 8, 9 & 3 (apoptosis) were measured using real-time PCR and ELISA. 
2. LITERATURE REVIEW 
Metformin is the most widely used hypoglycemic drug for treatment of type 2 diabetes [1]. 
Accumulating evidences in recent years clearly showed that metformin possesses significant 
anti-cancer effects [1]. For instance, the incidences of various cancer and cancer-related 
mortality have been found to be significantly lower in type 2 diabetic patients treated with 
metformin than in those treated with other types of anti-diabetes drugs. Numerous pre-clinical 
studies have shown that metformin suppresses proliferation and induces apoptotic death in 
various cancer cells [2-3]. Metformin has also been shown to prevent lung tumorigenesis 
caused by tobacco carcinogens and enhance the response of experimental tumors to 
chemotherapy and radiotherapy. 
A number of divergent cellular and molecular mechanisms have been proposed to account for 
the anti-cancer effects of metformin. The mechanism by which metformin produces its inhibitory 
effect on cancer development and tumor growth is not completely understood. These could be 
through indirect effects on systemic levels of insulin or glucose or through direct effects on 
tumor cell growth and survival. However it is known that metformin disrupts the oxidative 
phosphorylation in mitochondria, thereby decreasing ATP level and concomitantly increasing 
AMP level [1]. Direct effects of metformin on cancer cells include inhibition of cell proliferation 
and induction of cell death. 
In the studies where metformin has been shown to promote cell death, the mechanism appears 
to involve activation of apoptotic pathways. Nontransformed breast epithelial cells were also 
resistant to the cytotoxic effects of metformin [3]. In sensitive cell lines, cell death was mediated 
by both caspase-dependent and caspase-independent mechanisms. The caspase-independent 
pathway involved activation of poly(ADP-ribose) polymerase (PARP), was associated with 
mitochondrial enlargement, and was reduced by depletion of apoptosis inducing factor (AIF) [2]. 
It is well-established that moderate hyperthermia at 39-43°C kills cancer cells and sensitizes 
cancer cells to chemotherapy or radiotherapy. Lee et al (2014) showed that metformin is 
preferentially cytotoxic to cancer stem cells (CSCs) relative to non- CSCs and that hyperthermia 
markedly increase the metformin cytotoxicity against CSCs [1]. 
3. FINDINGS 
In this research a combination of Metformin and hypo- or hyperthermia was applied. However 
before that, the 50% (IC50) cell death for MG-63 cells was determined after 48h of incubation. 
We could show that 30M of Metformin was sufficient to kill 50% of MG-63 cells. Next, we 
determined the combined effect of Metformin and various temperatures on MG-63 cells after 
30mins, 1h and 2h. Our results showed that increase in temperature severity and incubation 
time lead to significant reduction in cell viability. This was observed when MG-63 cells 
preincubated with Metformin followed by exposure to severe hyperthermia at 45°C resulted in 
significant reduction in cell viability. Next we examined if combined treatment of Metfomin and 
temperature leads to DNA damage. By accessing with Comet assay stained with SYBR® 
Green, MG-63 cells in combination with Metformin and severe hyperthermia conditioning lead to 
Grade 4 DNA damage. Even though DNA damage was observed with response to moderate 
and severe hypothermia, damage was graded at stage 1, 2 and 3. Our results showed that 
increase in DNA damage responded according to temperature severity. 
Given that DNA damage was observed with response to combined Metformin and hypo- or 
hyperthermia treatment, we measured the rate of apoptotic cells to determine if cells were 
undergoing apoptosis. The combined treatment of Metformin with hypo- or hyperthermia 
increased the rate of apoptosis compared to cells treated with Metformin alone. Significant 
increase in apoptosis was observed when MG-63 cells exposed to 45°C. 
MG-63 cells that were treated with hypo- and hyperthermia in combination with metformin 
expressed higher levels of Hsp60 as compared to cells treated with metformin alone. This 
suggests the role of this protein in chaperoning temperature-induced protein misfolding. 
Meanwhile the expression of Hsp27 and Hsp70 was reduced in response to hypothermia and 
hyperthermia suggesting their anti-apoptotic function was halted in response to temperature 
exposure. The apoptosis inducing factor (AIF) was overexpressed in response to severe 
hyperthermia. Expression of intrinsic apoptotic caspase-9 was seen to be increased in response 
to both moderate and severe hypo- and hyperthermia at all time points. The execution of 
apoptosis measured by caspase-3 was expressed at basal level except in response to 2 h of 
severe hyperthermia. No combined effect was observed in response to moderate and severe 
hypo- and hyperthermia except at 2 h of severe hyperthermia. 
The combination of metformin and hyperthermia significantly downregulated the expression of 
AKT1 and GSK3/3, which in turn led to a reduction in cell viability and an increase in DNA 
damage. The combined effect caused an upregulation of DR5, Bax, Bid found upstream of 
mitochondrial signalling molecules and a downregulation of anti-apoptotic Bcl-2. The intrinsic 
pathway was not activated as the expression of AIF and cytochrome c was downregulated. 
Although Apaf-1 upregulated caspase 9, caspase 3 remained downregulated. 
4. CONCLUSION 
By looking at the results we have up to date, damage to DNA and rate of apoptosis are highly 
dependent on temperature severity and exposure duration. The adjuvant effect of metformin 
with severe hyperthermia showed increase in DNA damage and apoptosis, suggesting a 
possible anticancer activity of metformin. The combination of metformin with hyperthermia 
particularly 45°C, enhances apoptosis via Bax/Bid-dependent pathway. This pathway is either 
directly p53-mediated or through direct activation of caspase 7. 
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